Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update
New York, Jan 12, 2026, 10:13 ET — Regular session Teva Pharmaceutical Industries’ U.S.-listed shares jumped roughly 4% to $33.29 in Monday morning trading. The boost came after the drugmaker unveiled new funding for an experimental vitiligo treatment and offered